Skip to main content

Table 5 Single-factor logistic analyses

From: Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs

Baseline data

P

OR (95% CI)

group

0.041*

1.965 (1.026–3.761)

Male (n, %)

0.036*

2.212 (1.005–4.639)

Age (years)

0.079

0.977 (0.952–1.003)

Combined therapy (n, %)

0.177

0.647 (0.344–1.271)

BMI (kg/m2)

0.272

0.937 (0.834–1.052)

WBC (×109/L)

0.352

0.919 (0.770–1.098)

NE%

0.285

0.189 (0.009–3.999)

NE (×109/L)

0.157

0.846 (0.671–1.067)

RBC (×1012/L)

0.671

0.886 (0.508–1.547)

HB (g/L)

0.603

1.005 (0.985–1.026)

RDW (%)

0.240

0.837 (0.622–1.126)

PLT (×109/L)

0.955

1.000 (0.955–1.004)

PT (s)

0.065

1.362 (0.981–1.890)

PTA (%)

0.004*

0.959 (0.932–0.987)

INR

0.732

1.505 (0.145–15.615)

F (g/L)

0.643

0.918 (0.638–1.321)

APTT (s)

0.546

1.020 (0.957–1.086)

APTTR

0.216

3.879 (0.452–33.267)

TT (s)

0.648

1.051 (0.848–1.303)

TTR

0.694

1.925 (0.074–50.085)

TB (umol/L)

0.873

0.999 (0.991–1.007)

DBIL (umol/L)

0.891

0.999 (0.990–1.009)

TP (g/L)

0.450

0.982 (0.937–1.029)

A (g/L)

0.370

0.975 (0.920–1.031)

ALT (U/L)

0.000*

1.003 (1.002–1.003)

AST (U/L)

0.000*

1.004 (1.002–1.006)

ALP (U/L)

0.507

1.004 (0.991–1.018)

r-GT (U/L)

0.135

1.005 (0.998–1.011)

FBG (mmol/L)

0.896

0.986 (0.801–1.214)

BUN (mmol/L)

0.441

0.904 (0.700–1.168)

CR (mmol/L)

0.014*

0.970 (0.946–0.994)

UA (umol/L)

0.635

1.001 (0.998–1.004)

TC (mmol/L)

0.088

0.790 (0.602–1.036)

TG (mmol/L)

0.250

0.780 (0.511–1.191)

HDL-C (mmol/L)

0.769

1.161 (0.428–3.153)

LDL-C (mmol/L)

0.022*

0.668 (0.473–0.944)

HBsAg S/CO

0.979

1.000 (1.000–1.000)

HBeAg S/CO

0.945

1.000 (0.999–1.001)

HBV DNA Log10IU/mL

0.061

0.774 (0.592–1.012)

  1. *single-factor logistic regression P < 0.05